JCPRX
Price
$25.64
Change
-$0.23 (-0.89%)
Updated
Jul 13 closing price
Net Assets
3.7B
VTSAX
Price
$179.98
Change
-$1.44 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

JCPRX vs VTSAX

JCPRX vs VTSAX Comparison Chart in %
View a ticker or compare two or three
VS
JCPRX vs. VTSAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCPRX is a Buy and VTSAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 2.3T vs. JCPRX (3.7B). VTSAX pays higher dividends than JCPRX: VTSAX (1.04) vs JCPRX (0.13). JCPRX was incepted earlier than VTSAX: JCPRX (20 years) vs VTSAX (26 years). JCPRX (1.54) is less costly to investors than VTSAX (0.04). JCPRX is a more actively managed with annual turnover of: 100.00 vs. VTSAX (3.00). JCPRX has a lower initial minimum investment than VTSAX: JCPRX (0) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 21.47 vs. JCPRX (13.14). VTSAX return over 5 years is better than : 66.46 vs. JCPRX (-8.50).
JCPRXVTSAXJCPRX / VTSAX
Total Expense Ratio1.440.043,600%
Annual Report Gross Expense Ratio1.540.043,850%
Fund Existence20 years26 years-
Gain YTD7.92711.20771%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.7B2.3T0%
Annual Yield % from dividends0.131.0413%
Returns for 1 year13.1421.4761%
Returns for 3 years42.4567.0063%
Returns for 5 years-8.5066.46-13%
Returns for 10 years-3.45250.48-1%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CEMVX18.58N/A
N/A
Causeway Emerging Markets Investor
GSMYX25.93N/A
N/A
Goldman Sachs Small/Mid Cap Growth Instl
VGSIX32.36N/A
N/A
Vanguard Real Estate Index Investor
TBWCX21.92N/A
N/A
Thornburg Better World International C
MCYVX16.17-0.50
-3.00%
NYLI Candriam Emerging Markets Eq Inv Cl